chrisvoncsefalvay/vaers-outcomes huggingface dataset:
having strong menstruations lately; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (having strong menstruations lately) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (having strong menstruations lately). At the time of the report, HEAVY MENSTRUAL BLEEDING (having strong menstruations lately) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medication was not reported.   The treatment history was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Sep-2021: Non significant follow up received on 27-SEP-2021 and does not contain any new information
Mother reports child received influenza vaccine on 10/22/2014 at a community free flu shot clinic. Mom contacted this office on 10/24/2014 reporting whole upper arm as red swollen, hard, and hot to touch. Child then seen in clinic by doctor. Diagnosis vaccine reaction, treatment Ibuprofen, Benadryl, and cool compresses.
Patient was 4 years old at the time on November 12, 2021. He was given the first dose Pfizer for Pediatrics at the dosage of 0.2 mL by Intramuscular route in the left arm. As of today patient has not reported of having no life threatening adverse effects or urgent care needed. This accidental vaccination at the time was caught and brought to our attention.
Had immunizations for 6 months on 01/13/04.  Seen in office on 02/02/04 for 5x6cm tender, indurated area on left anterior thigh.  Upper 1.8x1.5cm area of erythema, lower 2.0x2.5cm area of erythema: at sites of injection.  Diagnosis: delayed immunization reaction.  Prescribed: Augmentin and warm soaks to recheck in 7 days.
Later in the evening (Nov 15, 2018) after receiving FLUZONE HD she had pain around the injection site and localized swelling. She states today (Dec. 13, 2018) that she still has pain in the arm (mid muscle and down the arm) and cannot lie on the arm.
FEVER; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccinationThe batch number was not reported and has been requested.  No concomitant medications were reported. On an unspecified date, the subject experienced fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101 deg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever. This report was non-serious.
Patient was given 0.5mg of moderna bivalent but was to receive 0.25mg of moderna bivalent for booster dose.
Patient reported being dizzy, tired, confused since day after vaccination. Someone said he looked clammy and flushed at work today so he was sent home to rest.
No adverse event; PEDVAX HIB vaccine was administered when mixed with Merck diluent and administered IM; This spontaneous report has been received from a medical assistant concerning a 4-month-old patient of an unknown gender. The patient's concomitant therapies, drug reactions or allergies, medical history, and concurrent conditions were not provided.   On 31-MAY-2022, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PEDVAXHIB) administrated intramuscularly (IM) (formulation, strength, dose, vaccination scheme, and anatomical site of vaccination were not reported, lot number U034518, which has been verified to be valid, expiration date reported and validated as 28-MAR-2024), as prophylaxis. The sterile diluent (MERCK STERILE DILUENT) (lot number T025911, which has been verified to be valid, expiration date reported and validated as 08-MAR-2023) was used to reconstitute the vaccine (medication dilution) (Product preparation issue). No adverse events details were given.
Received vaccine (2nd dose) at 9:28 a.m.  Felt fine all day.  That night, awakened off and on while sleeping, and felt "warmer than usual".  On arising at 6:00 a.m., took oral temperature, and it was 101 F.  Fever persisted throughout the day, along with fatigue and slight shortness of breath.  Slept most of the day, and the next night,  Upon arising today felt totally normal with no fever.
Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Dizziness /Lightheadedness-Mild, Systemic: Exhaustion/Lethargy-Medium, Systemic: Fever-Mild, Systemic: burning sensation in skin-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extremities)-Medium, Systemic: Weakness-Mild, Additional Details: numbness and tingling in arm, back and spine. Patient states symptoms felt like shingles. Loss of feeling from mid-spine up. Burning sensation on upper, left shoulder.
Swelling and soreness of lymph in armpit. Pain and swelling increased the next following mornings 10/24-25/2015. May be the result of aluminum allergy and not being aware aluminum salts were used in Flu vaccinations. Flu shot was administered by a man whose job is to go around the hospital and administer the flu shot. Manufacturer in unknown and will be randomly input.
This case was reported by a other health professional via call center representative and described the occurrence of rash in a female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included allergic reaction to antibiotics and drug allergy. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced rash and muscle pain. On an unknown date, the outcome of the rash and muscle pain were unknown. It was unknown if the reporter considered the rash and muscle pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced a localized rash and muscle pain, with a severity of 5 by 10. The healthcare professional called from an internal medicine office, to obtain a list of ingredients to check for cross-sensitivity between patient allergies. The patient was given the vaccine at a pharmacy and not at the physician office. The healthcare professional had no further information.
Five days, post vax, he had a mild rash and minimal swelling at the injection site. Resolved with ibuprofen and warm soaks.
Information has been received from a consumer concerning the brother of her daughter's classmate who on an unknown date was vaccinated with MMR II. It was reported that the patient developed a rash from shoulder to elbow after receiving MMR II. The patient's final outcome was not reported. Attempts to verify the existence of identifiable patients have been unsuccessful. This is one of two reports received from the same source. No further information is available.
I had Flu like symptoms for 3 days. Then I was so tired, and my muscles and knees hurt all the time. Went to doctor about my legs hurting. The doctor says it's arthritis, and orthopedic doctor confirms it is probably arthritis. Typically after 3 pm, I need to nap. I am also experiencing headaches that are not normal.
Patient is MD 82 year old male who presents today for acute visit. He received a flu vaccine on 09/28/17 into the left deltoid. On 10/11/17 he developed pain around the right shoulder girdle. This progressed to weakness and inability to abduct the right arm. He was suspected to have acute brachial neuropathy. He was seen by Dr. (neurology) and was diagnosed with Parsonage-Turner Syndrome and was started on a medrol dosepak. He no longer has paralysis but continues to have weakness. His pain is improved but not resolved. He notes that the pain is worse at night. He will having a follow up appointment with neurology on 10/31/17. Pain is currently a 2/10, described as a constant pressure/pain. For a short amount of time, maybe 2-3 hours, he had tingling/numbness of the 4th and 5th digits but this resolved and has not recurred.
Tachycardia up to 160 with exertion. Some shortness of breath noted. Returns to normal heart rate with rest. Cardiac monitor, CXR, CBC, TSH, CMP in the Emergency Department and physician evaluation.  Returned to work same day without restrictions.  Will follow up with personal provider.
This spontaneous report was received from a licensed practical nurse regarding a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 05-OCT-2015, the patient was vaccinated with expired dose of (Oka/Merck) VARIVAX (dose: 0,5 ml/once, route subcutaneous, lot # J007954, expiration date 27-JUN-2015). There were no adverse effects reported. Additional information has been requested.
On 3-25-09 pt presented with classic herpes zoster outbreak (R) side torso (not crossing midline).
Customer called for a temperature excursion and reported VAQTA and MMR II that had undergone temperature excursion were administered to patients before calling Agency. No additional AE reported. No PQC reported. No further information was provided.; No additional AE reported. No PQC reported. No further information was provided.; This spontaneous report was received from a medical assistant concerning to an unspecified number of patients of unspecified ages and genders. They're, medical history, historical drugs, known allergies,, concurrent conditions and concomitant therapies were not reported.  On an unspecified dates, the were vaccinated with doses of hepatitis a vaccine, inactivated (VAQTA) lot #W017343 (expiration date: 13-DEC-2023); and measles, mumps, and rubella (Wistar ra 27-3) virus vaccine, live human recombinant albumin (rHA) (M-M-R II) lot##W012118 (expiration date: 24-DEC-2023) that upon internal review was confirmed to be a valid lot# for measles, mumps, and rubella (Wistar ra 27-3) virus vaccine, live human recombinant albumin (rHA) (M-M-R II) both administered for prophylaxis (strengths, doses, frequencies, and routes of administration were not provided) that had gone trough a temperature excursion at 24 degrees Fahrenheit [F]) during 14 hours (Improper storage of product in use), no previous temperature excursion had occurred and further information was not provided.  This case is non-valid due to the lack of patient identifiers.
78-year-old male presents to the emergency department 8/11/2022 after experiencing syncopal episode.  Patient was doing quite well at his home until this past weekend when he started to have mild upper respiratory symptoms.  At home COVID test was positive.  Patient was started on Paxil but on 8/8/2022.  Patient took 3 doses prior to his arrival.  Patient apparently had a syncopal episode the night before his presentation and he remained on the floor overnight.  When patient was seen in the emergency department patient has evidence of rhabdomyolysis with increased creatinine.  Patient was started on IV fluids.  His procalcitonin was also elevated and patient was still on antibiotics for possible community-acquired. pneumonia.   Patient was seen by infectious disease.  He was started on IV azithromycin and Rocephin as well as Decadron and remdesivir.  Patient finished 5-day course of remdesivir.  Cardiology also evaluated the patient, believing that his syncopal episode was most likely vasovagal attack with no further work-up needed at this time patient was seen by physical therapy patient declined subacute rehab placement.  Patient requested home care which was set up by care management. Patient was cleared by all specialties.
Pattient recieved MMR-Varicella (Proquad)and pneumococcal (Prevnar) vaccine at hospital on 9/15/06. Patient was also diagnosed with otitis media during the same visit and was prescribed Amoxicillin. Patient developed a rash on 9/24, initially on the face, that spread to the rest of her body on 9/25; rash was red, blotchy, and pruritic. There was no fever or associated URI symptoms. Patient was seen by me on 9/26 for evaluation of rash, crankiness, decreased po intake. Rash is characterized as a morbilliform, generalized body rash; no edema; no wheezing; remainder of exam was normal. Amoxicillin was discontinued that day, and patient was placed on Benadryl Q6 hours. Patient followed up on 9/27; significant improvement of rash, with decreased redness, no complaints of pruritis while on Benadryl. It is unclear if this is a post-measles vaccination rash or an allergic reaction to Amoxicillin.
pt recvd MMR on 19NOV92; devel swelling (not painful) of rt testicle on 25NOV92; the swelling went down by itself on 27NOV92; low grade fever;
Patient reported rash along the length of her arm, from shoulder to wrist.  Slightly raised pink bumps.
Since getting both doses. I have experienced multiple upper respiratory infections and experiencing body aches. Each time I get sick it is taking me 2 weeks or longer to get over the illness. I have had upper respiratory infections in March, May June and august. I was tested for covid each time. But all test came back negative. I now have sob and dizziness almost daily.
Moderna 5/6/21, 6/4/21. Positive on 6/28/22
My Arm was swollen and the injection site.. Swollen Lymph Nodes . Low grade fever
have a 101, average temperature since taking the vacine two days ago; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (have a 101, average temperature since taking the vacine two days ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (have a 101, average temperature since taking the vacine two days ago). At the time of the report, PYREXIA (have a 101, average temperature since taking the vacine two days ago) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was received by the patient  No Treatment was received by the patient.
This spontaneous report was received from a health professional refers to unspecified patients of unknown gender and age. Information regarding patients' medical history, concurrent condition, drug reactions/allergies and concomitant medications were not reported. On unspecified dates, these patients were vaccinated with incorrectly stored single dose vials of PNEUMOVAX 23 (lot # L019835, expiry date: 23-MAR-2017). The vaccine doses were exposed to the following conditions: 1.7 degree C temperature, for a time frame of 3 months. There were no previous excursions. No adverse experience was reported. Additional information has been requested.
12DEC97 rt jaw area swollen x 24hr;no injury;rt eye hurst-watery;dx acute rt parotitis;
No AE; Caller reported vaccine administered after temperature excursions.  No additional information provided.  No additional AEs or PQC reported.       ?    Names of vaccines involved (including lot/exp) VARIVAX X006983  3/7/2025          ?    Temperat; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 10-AUG-2023, the patient was vaccinated with an improperly storage varicella virus vaccine live (OKA/MERCK) (VARIVAX) subcutaneous injection, 0.5 milliliter, valid lot #X006983, expiration date: 07-MAR-2025, administered intramuscularly for prophylaxis (strength was not provided) (Product storage error). Temperature excursion occurred at 18.3F for 1 hour and 5 minutes. No previous temperature excursion was reported. No additional adverse events were reported.
Several hours post vax pt experienced hives continuing for 48 hours and prompting ER visit. Pt treated with 125mg Solu-medrol, 50mg IV Benadryl, and 20mg IV Pepcid. Sent home on 60 mg prednisone for 5 days. Full recovery within 30 hours. Pt experienced spontaneous re-emergence of urticaria requiring a 2nd ER visit. Reportedly the pt recovered from this episode.
Left shoulder pain, which I initially assumed was just general vax pain.  At the 2nd dose of Moderna, the pain was still present and has never relented in 15 months.  Pain is with specific reaching movements.  Seen by MD at Orthopedics and thought to be a vaccine injury probably related to administration (vax site seemed high)
A spontaneous report received from a health professional, concerns a patient of unknown gender. No information regarding concomitant disease and concomitant medications was provided. On an unknown date, patient was given FLUMIST (intranasal) 0.2 millilitres, yearly, unknown time prior to hospitalization. Patient hospitalized with viral infection and critical illness and was intubated. Action taken with FLUMIST QUADRIVALENT was unknown. The outcome of viral infection and critical illness was unknown. Company physician assessed viral infection and critical illness as serious due to hospitalization.
CHILD'S DATE OF BIRTH WRITTEN INCORRECTLY AND AGE WRITTEN AS 12 ON SIGNED CONSENT. CHILD IDENTIFIED IN DATABASE WITH A DIFERENT DOB CHILD TOO YOUNG FOR VACCINE IN 10/2021.
Kinrix was given at age 8 years.  Kinrix is recommended for children ages 4-6 years. Consulted with MD and no additional vaccines will be needed at this time. DTAP and IPV will count on immunization vaccine record.
Patient got  PREVNAR 13 on 04/05/2017 and another one on 04/17/2018. no adverse events reported by patient but got PREVNAR 13 instead of PNEUMOVAX 23 on 04/17/18.
p/vax pt taken to hosp T103 & began sz;pt started in Tegretol & referred to peds neuro for f/u;
soreness, swelling and fever on her arm; soreness, swelling and fever on her arm; fever; A spontaneous report was received from a consumer concerning an 80 year old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed sore arm/pain in extremity, swollen arm/peripheral swelling, and fever/pyrexia.  The patient's medical history was not provided. Concomitant medications reported were potassium, vit B12, furosemide, calcium, gabapentin, high blood pressure medication and lisinopril.  On 05 Jan 2021 the patient received their first of two planned doses of mRNA-1273 (batch number not provided) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 01 Feb 2021, approximately two days prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (batch number not provided) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   The patient experienced a fever and arm soreness and swelling on 03 Feb 2021.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events sore arm, swollen arm, and fever were not reported.  Reporter causality for the events was not provided.; Reporter's Comments: This case concerns an 80-year-old female who experienced nonserious unexpected events of pain in extremity and peripheral swelling and nonserious expected event of fever. The events occurred 2 days after the second dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt got vaccine on 3-7-21, by 8 PM, "severe joint pain" her knuckles, hips and hips felt swlooen and very painful.  Took advil and Tylenol with no relief. Finally at 2am, pt took 2 dilaudid and felt better around 4am. She states that she continues to have some HA and neck pain,  (3-8) this pain in tolerable.  Pt states that she has PMH of fibromyalgia and wonders if this is playing a role in her reaction.  Would like a VAERS report done.
I started getting numbness on my right sight of my body - mostly in arm and leg. Could feel the coldness all down that arm and leg. It lasted about a week. As the week moved on I felt it in both of my legs (and not as much in the arm)- coldness with also a burning a sensation. I work in an EMT office, I was still having it at work on Monday. Drs (not an official visit, I just work there) at work gave me a steroid shot and put me on a 5 day course of oral steroids. Within 5 days it was better and by Sunday it had pretty much gone away.
After my first dose of the Pfizer vaccination I had problems with my chest and heart beat only a few hours after the initial shot. Along with the normal sore arm, I had chest pain, fast heart rate and trouble breathing. As someone who is very athletic and could run up the stairs on a normal basis, this was extremely abnormal. I could be sitting or laying down completely still, having not done any movement, and these symptoms of rapid heart rate, chest pain, and shortness of breath would return.
Chest pain, fever, soreness in left chest area, swollen lymph gland, cold-like symptoms.
This spontaneous report was received from a nurse via company representative, referring to a male patient in his early 60s. The patient's medical history, concurrent conditions, drug and allergy history were not provided. On an unknown date (reported as "a few years ago"), the patient was vaccinated with ZOSTAVAX (strength, dose, frequency, administration route, lot number and expiration date were not provided), for prophylaxis. Concomitant therapies included a sterile diluent. It was reported that on an unspecified date (reported as "a few months ago"), the patient went to the office and was diagnosed with shingles. It was also stated that the nurse was not interested in a Varicella-Zoster Virus (VZV) analysis by polymerase chain reaction (PCR). The outcome of herpes zoster was unknown. The causality assessment between ZOSTAVAX and the event was not reported.
Fevers up to 103, swelling pain and redness at the deltoid at the site of his injection.